ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.98 CNY | -0.88% |
|
-4.07% | -21.79% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2021 | 1.38B 191M | Sales 2022 | 1.57B 217M | Capitalization | 3.68B 509M |
|---|---|---|---|---|---|
| Net income 2021 | 120M 16.59M | Net income 2022 | 127M 17.56M | EV / Sales 2021 | 1.98 x |
| Net cash position 2021 | 747M 103M | Net cash position 2022 | 458M 63.3M | EV / Sales 2022 | 2.06 x |
| P/E ratio 2021 |
28.6
x | P/E ratio 2022 |
29.1
x | Employees | 981 |
| Yield 2021 |
0.83% | Yield 2022 |
1.11% | Free-Float | 51.34% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.88% | ||
| 1 week | -4.07% | ||
| Current month | -0.24% | ||
| 1 month | +8.22% | ||
| 3 months | +17.27% | ||
| 6 months | -20.88% | ||
| Current year | -21.79% |
1 week
16.93
19.33
1 month
13.8919.33
Current year
11.8422.04
1 year
11.8422.59
3 years
11.8425.79
5 years
11.8433.19
10 years
11.8433.19
| Managers | Title | Age | Since |
|---|---|---|---|
Song Ying Mao
DFI | Director of Finance/CFO | 46 | 21-01-04 |
Nan Ping Fang
CHM | Chairman | 57 | 14-12-08 |
Lin Li Zhao
BRD | Director/Board Member | 41 | 21-01-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiu Fang Zhao
BRD | Director/Board Member | 55 | 21-01-04 |
Nan Ping Fang
CHM | Chairman | 57 | 14-12-08 |
Hui Hao Lu
BRD | Director/Board Member | 54 | 14-12-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 16.98 | -0.88% | 2 007 973 |
| 24-05-13 | 17.13 | -1.55% | 2,430,662 |
| 24-05-10 | 17.4 | -3.76% | 4,562,529 |
| 24-05-09 | 18.08 | -2.80% | 6,434,082 |
| 24-05-08 | 18.6 | +3.97% | 7,526,762 |
End-of-day quote Shenzhen S.E., May 13, 2024
More quotes
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a China-based company principally engaged in the research, development, production and sales of chemical raw materials and preparations. The Company's products mainly include cephalosporin and penicillin series, anti-hypertension series, digestive system series, kidney disease series and others.
Sector
Pharmaceuticals
Calendar
2024-05-15
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -21.79% | 468M | |
| +30.86% | 682B | |
| +30.35% | 586B | |
| -3.53% | 364B | |
| +18.15% | 327B | |
| +3.93% | 285B | |
| +15.53% | 240B | |
| +10.16% | 209B | |
| -8.14% | 203B | |
| +8.13% | 165B |
- Stock Market
- Equities
- 002940 Stock